Law360, New York (March 11, 2013, 12:35 PM EDT) -- Lately, the cosmetics industry — particularly with respect to anti-aging products — has been a popular target for both the U.S. Food and Drug Administration and plaintiffs. Because FDA warning letters and lawsuits can create unwanted press and costs for companies, it is important for inside and outside counsel to work together to recognize potential risks of increased FDA scrutiny and the potential consequent risk of future class actions lawsuits.
FDA Warning Letters to Anti-Aging Product Manufacturers
In the fall of 2012, the FDA was busy admonishing...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.